Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Gabriela Critchi"'
Autor:
Guilherme Nader Marta, Luís G. Del Nero, Gustavo Nader Marta, Andrea Mangabeira, Gabriela Critchi, Maria J. Kovács, João Luis Fernandes da Silva, Everardo D. Saad
Publikováno v:
Clinics, Vol 69, Iss 8, Pp 509-514
OBJECTIVES: Despite the progress achieved in the fight against cancer over the past several years, assessing the needs, goals and preferences of patients with cancer is of the utmost importance for the delivery of health care. We sought to assess pri
Externí odkaz:
https://doaj.org/article/d58460aaa63e46288acf7dcc5b010444
Autor:
Carlos Artigas, Gabriela Critchi, Patrick Flamen, Nieves Martinez Chanza, Thierry Gil, Alexandre Peltier, Qaid Ahmed Shagera, Spyridon Sideris, Ioannis Karfis, Marianne Paesmans
Publikováno v:
Journal of Nuclear Medicine. 63:1191-1198
Aim: We aimed to evaluate the role of Positron Emission Tomography (PET) targeting the Prostate-Specific Membrane Antigen (PSMA) for response assessment in metastatic prostate cancer (mPCa) patients treated with taxane-based chemotherapy (docetaxel o
Autor:
Magdalena Mileva, Hugo Levillain, Gwennaëlle Marin, Gabriela Critchi, Clementine Marin, Patrick Flamen, Ioannis Karfis
Publikováno v:
6th International Conference on Radiopharmaceutical Therapy (ICRT 2021) Abstracts.
Autor:
Federica Marmorino, Lisa Salvatore, Alain Hendlisz, Patrick Flamen, Dario Genovesi, Lieveke Ameye, Erwin Woff, Thomas Guiot, Gabriela Critchi, Francesco Sclafani
Publikováno v:
Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 63(4)
Stratification of metastatic colorectal cancer (mCRC) patients is mostly based on clinical and biologic characteristics. This study aimed to validate the prognostic value of 18F-FDG PET/CT-based biomarkers such as baseline whole-body metabolically ac
Autor:
Tugba Akin Telli, Françoise Rothé, Francesco Sclafani, Caroline Vandeputte, Gabriela Critchi, Silvia Camera, Giacomo Bregni, Chiara Senti, Elena Trevisi, Yacine Wissam, Frédéric Hoerner, Amélie Deleporte, Paraskevas Gkolfakis, Andrea Pretta, Pashalina Kehagias, Patrick Flamen, Alain Hendlisz, Erwin Woff, Thomas Guiot, Sophia Leduc
Publikováno v:
Cancers
Volume 12
Issue 10
Cancers, 12 (10
Cancers, Vol 12, Iss 2752, p 2752 (2020)
Cancers (Basel), 12 (10
Volume 12
Issue 10
Cancers, 12 (10
Cancers, Vol 12, Iss 2752, p 2752 (2020)
Cancers (Basel), 12 (10
Introduction: Decision making in refractory colorectal cancer (rCRC) is challenging, with limited data available to predict patient outcome. We conducted a study to assess the pace of cancer progression as a potential prognostic and decision tool. Me
Autor:
Erwin Woff, Thomas Guiot, Alain Hendlisz, Dario Genovesi, Lisa Salvatore, Assuero Giorgetti, Lieveke Ameye, Alfredo Falcone, Hugo Levillain, Patrick Flamen, Gabriela Critchi, Federica Marmorino, Marianne Paesmans
Publikováno v:
Journal of Clinical Oncology. 37:3543-3543
3543 Background: This study aimed to develop and validate a prognostic score integrating baseline metabolically active tumor volume (MATV) and clinical factors in metastatic colorectal cancer (mCRC) patients. Methods: The development cohort included
Autor:
Rachel P. Riechelmann, Gabriela Critchi, Andrea Mangabeira, Felipe Yu Matsushita, Diego de Araujo Toloi, Everardo D. Saad, Paulo M. Hoff
Publikováno v:
ecancermedicalscience
BACKGROUND: Cancer can influence the views of patients on treatment goals and make them different from those of health care professionals (HCPs). It is crucial to understand patient expectations regarding cancer treatment. METHODS: We performed a cro
Autor:
João Luis Fernandes da Silva, Maria Júlia Kovács, Gustavo Nader Marta, Everardo D. Saad, Gabriela Critchi, Luis Guilherme Del Nero, Andrea Mangabeira, Guilherme Nader Marta
Publikováno v:
Clinics, Volume: 69, Issue: 8, Pages: 509-514, Published: AUG 2014
Clinics; v. 69 n. 8 (2014); 509-514
Clinics; Vol. 69 Núm. 8 (2014); 509-514
Clinics; Vol. 69 No. 8 (2014); 509-514
Clinics
Universidade de São Paulo (USP)
instacron:USP
Clinics, Vol 69, Iss 8, Pp 509-514
Clinics; v. 69 n. 8 (2014); 509-514
Clinics; Vol. 69 Núm. 8 (2014); 509-514
Clinics; Vol. 69 No. 8 (2014); 509-514
Clinics
Universidade de São Paulo (USP)
instacron:USP
Clinics, Vol 69, Iss 8, Pp 509-514
OBJECTIVES: Despite the progress achieved in the fight against cancer over the past several years, assessing the needs, goals and preferences of patients with cancer is of the utmost importance for the delivery of health care. We sought to assess pri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a8694a45a69da8ae75c73830a593f3fc
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322014000800509&lng=en&tlng=en
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322014000800509&lng=en&tlng=en
Autor:
Everardo D. Saad, Gabriela Critchi, Paulo M. Hoff, D.A. Toloi, Rachel P. Riechelmann, Felipe Yu Matsushita, Andrea Mangabeira
Publikováno v:
Annals of Oncology. 25:iv483
Aim: Cancer diagnosis can impact the view of pts and HCP on treatment goals. Therefore, it is crucial to understand their expectations in terms of how aggressive the oncologic approach should be in order to preserve survival time (ST) and/or quality
Autor:
Tugba Akin Telli, Françoise Rothé, Leila Shaza, Caroline Vandeputte, Patrick Flamen, Andrea Pretta, Chiara Senti, Francesco Sclafani, Amélie Deleruelle, Frédéric Hoerner, Silvia Camera, Alain Hendlisz, Amélie Deleporte, Gabriela Critchi, Giacomo Bregni, Elena Trevisi, Pashalina Kehagias, Erwin Woff, Thomas Guiot, Sophia Leduc
Publikováno v:
Web of Science
e16012 Background: Decision making in rCRC patients (pts) who have exhausted all available therapies is challenging. Clinical trials, treatment re-challenge and best supportive care are possible options. There are limited data, however, to predict pt
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80884f4bebfa06a71e1471b8cc7f6944
https://publons.com/wos-op/publon/54204212/
https://publons.com/wos-op/publon/54204212/